The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 79-84, January 2010

Advances in adult asthma diagnosis and treatment in 2009

  • Andrea J. Apter, MD, MSc

      Affiliations

    • Corresponding Author InformationReprint requests: Andrea J. Apter, MD, MSc, 829 Gates Bldg, Hospital of the University of Pennsylvania, 3600 Spruce St, Philadelphia, PA 19104.

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, Pa

Received 17 November 2009; accepted 19 November 2009.

There is a growing need to standardize and validate outcomes for asthma research. In this review of asthma-related publications from the Journal in 2009, efforts to standardize methodology and reporting of translational research, the influence of the environment, therapeutics, and management of asthma are highlighted.

Key words: Asthma, adults, genetics, inhaled corticosteroids, nitric oxide, health disparities, biomarker, leukotriene modifier, obesity

Abbreviations used: BF, Budesonide/formoterol, BMI, Body mass index, ED, Emergency department, Feno, Fraction of exhaled nitric oxide, GSTM1, Glutathione-S-transferase M1 gene, HEDIS, Healthcare Effectiveness Data and Information Set, ICS, Inhaled corticosteroid, MBT, Mannitol bronchoprovocation test, PLAUR, Urokinase plasminogen activator receptor gene, TSLP, Thymic stromal lymphopoietin, UK, United Kingdom

 

 Disclosure of potential conflict of interest: A. J. Apter receives research support from the National Heart, Lung, and Blood Institute. A. J. Apter is supported by grants HL070392, HL088469, and RC1 HL099612.

PII: S0091-6749(09)01749-7

doi:10.1016/j.jaci.2009.11.028

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 79-84, January 2010

Article Tools